血管閉鎖デバイスの世界市場予測（～2022年）：コラーゲンプラグ、密閉剤/ゲル、クリップ、縫合装置...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions of the Study

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 29)
4.1 Vascular Closure Devices: Market Overview
4.2 Geographic Analysis: Vascular Closure Devices Market, By Type (2017)
4.3 Market, By Access, 2017 vs 2022
4.4 Market, By Procedure, 2017 vs 2022
4.5 Geographic Snapshot of the Vascular Closure Devices Market

5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Large Number of Approvals for Vascular Closure Devices
5.2.1.2 High Prevalence of Cardiovascular Diseases
5.2.1.3 Increasing Prevalence of Obesity
5.2.1.4 Increasing Focus of Market Players on Large-Bore Vascular Closure Devices
5.2.2 Restraints
5.2.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
5.2.2.2 High Cost of Vascular Closure Devices
5.2.2.3 Product Recalls and Failures
5.2.3 Opportunity
5.2.3.1 Emerging Markets Providing Growth Opportunities for Market Players
5.2.4 Challenges
5.2.4.1 Need for Highly Skilled Professionals
5.2.4.2 Risks Associated With Vascular Closure Devices

6 Global Vascular Closure Devices Market, By Type (Page No. – 39)
6.1 Introduction
6.2 Passive Approximators
6.2.1 Collagen Plugs
6.2.2 Sealant Or Gel-Based Devices
6.2.3 Compression Assist Devices
6.3 Active Approximators
6.3.1 Suture-Based Devices
6.3.2 Clip-Based Devices
6.4 External Hemostatic Devices

7 Global Vascular Closure Devices Market, By Access (Page No. – 48)
7.1 Introduction
7.2 Femoral Access
7.3 Radial Access

8 Global Vascular Closure Devices Market, By Procedure (Page No. – 53)
8.1 Introduction
8.2 Interventional Cardiology
8.3 Interventional Radiology/Vascular Surgery

9 Global Vascular Closure Devices Market, By Region (Page No. – 57)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Rising Prevalence of Cardiovascular Diseases
9.2.1.2 Growing Trend of One-Day Surgeries for Vascular Procedures
9.2.1.3 Increase in Research and Clinical Trials for Vascular Closure Devices
9.2.1.4 Increasing Number of Conferences, Meetings, Symposia, and Workshops
9.2.2 Canada
9.2.2.1 Increasing Number of Cardiac Arrest Cases
9.2.2.2 Long Waiting Times for Cardiac Surgery Likely to Encourage the Adoption of Minimally Invasive Procedures
9.3 Europe
9.3.1 Increasing Focus of Market Players in the European Region
9.3.2 E-3
9.3.2.1 Increasing Number of Research Studies on Vascular Closure Devices in Germany
9.3.2.2 Rising Prevalence of CVDS in Germany
9.3.2.3 Increase in the Number of Radial Access Procedures in France and the U.K.
9.3.2.4 Growth in the Aging and Obese Populations in the U.K.
9.3.3 RoE
9.4 Asia-Pacific
9.4.1 Rapid Growth in the Aging Population in Japan & China
9.4.2 Cost—A Major Concern for Interventional Procedures in India
9.4.3 Healthcare Reforms, Government Initiatives, and Investments in China and Japan
9.5 Rest of the World

10 Competitive Landscape (Page No. – 85)
10.1 Introduction
10.2 Vendor Dive Overview
10.2.1 Vanguards
10.2.2 Innovators
10.2.3 Emerging Players
10.2.4 Dynamic Players
10.3 Competitive Benchmarking
10.3.1 Analysis of the Product Portfolio of Major Players in the Market (23 Companies)
10.3.2 Business Strategies Adopted By Major Players in the Market (23 Companies)

*Top 23 Companies Analyzed for This Study are – Tz Medical, Inc. (U.S.), Vasorum Ltd. (Ireland), Inseal Medical Ltd. (Israel), Morris Innovative Inc. (U.S.), Essential Medical Inc. (U.S.), Arstasis Inc. (U.S.), Tricol Medical Inc. (U.S.), Marine Polymer Technologies (U.S.), Hemostasis LLC (U.S.), Chitogen Inc. (U.S.), Endocor GmbH (Germany), Transluminal Technologies LLC (U.S.), Hemoband Corporation (U.S.), Vascualr Closure Systems Inc. (U.S.), Advanced Vascular Dynamics (U.S.), Scion Biomedical (U.S.), Terumo Corporation (Japan), Abbott Laboratories (U.S.), Cardinal Health, Inc. (U.S.), Cardiva Medical, Inc.(U.S.), Medtronic PLC (Ireland), Merit Medical Systems Inc. (U.S.), Vivasure Medical Ltd. (Ireland)

11 Company Profiles (Page No. – 89)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Terumo Corporation
11.2 Abbott Laboratories
11.3 Cardinal Health, Inc. (Cordis)
11.4 Cardiva Medical, Inc.
11.5 Medtronic PLC
11.6 Morris Innovative, Inc.
11.7 Essential Medical, Inc.
11.8 Merit Medical Systems, Inc.
11.9 Vasorum Ltd.
11.10 TZ Medical, Inc.
11.11 Vivasure Medical Ltd.
11.12 Inseal Medical Ltd.
11.13 Tricol Biomedical, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 120)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details